Amfepramon vs fenproporex vs mazindol vs sibutramine vs fluoxetine in obese premenopausal women

Trial Profile

Amfepramon vs fenproporex vs mazindol vs sibutramine vs fluoxetine in obese premenopausal women

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Nov 2012

At a glance

  • Drugs Amfepramone (Primary) ; Fenproporex (Primary) ; Fluoxetine (Primary) ; Mazindol (Primary) ; Sibutramine (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Nov 2012 Results published in the 2012 Annual Meeting of the North American Association for the Study of Obesity.
    • 14 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top